Santa Fe Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-15,919
Closed -$1.34M 181
2015
Q4
$1.34M Sell
15,919
-26,771
-63% -$2.22M 0.22% 181
2015
Q3
$3.57M Buy
+42,690
New +$3.6M 0.48% 57
2015
Q2
Sell
-41,784
Closed -$3.04M 546
2015
Q1
$3.04M Buy
41,784
+38,113
+1,038% +$2.71M 0.37% 81
2014
Q4
$254K Buy
+3,671
New +$248K 0.03% 444
2014
Q2
Sell
-9,644
Closed -$567K 551
2014
Q1
$567K Buy
+9,644
New +$538K 0.08% 336
2013
Q4
Sell
-51,385
Closed -$2.59M 524
2013
Q3
$2.59M Buy
51,385
+71
+0.1% +$3.72K 0.49% 55
2013
Q2
$2.52M Buy
+51,314
New +$2.79M 0.51% 14

Other funds holding LLY

Santa Fe Partners's LLY Position: Q1 2016 in Review

Santa Fe Partners sold out of Eli Lilly (LLY) in Q1 2016, closing a stake of 15,919 shares — an estimated $1.34M sold.

Santa Fe Partners first reported a position in LLY in Q2 2013 and held it in 7 quarters. The position peaked at $3.57M in Q3 2015. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • Santa Fe Partners reported no remaining Eli Lilly position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 15,919 Eli Lilly shares in Q1 2016, an estimated $1.34M.
  • Santa Fe Partners first reported a position in Eli Lilly in Q2 2013 and held it in 7 quarters.
  • Santa Fe Partners's Eli Lilly position peaked at $3.57M in Q3 2015.
  • 1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.